SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-17-002616
Filing Date
2017-09-05
Accepted
2017-09-05 16:36:22
Documents
1
Period of Report
2017-08-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1720525.html 3  
1 OWNERSHIP DOCUMENT zk1720525.xml 3 1546
  Complete submission text file 0001178913-17-002616.txt   3196
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Issuer) CIK: 0001062128 (see all company filings)

IRS No.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2890 Miscellaneous Chemical Products

Mailing Address 6725 MESA RIDGE ROAD SUITE 100 SAN DIEGO CA 92121
Business Address
Culley Brian M (Reporting) CIK: 0001310683 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24431 | Film No.: 171069137